Logo

Jooish

HomeSitesGroupsStatusPodcasts
Sign InSign Up
HomeSitesGroupsStatusPodcastsSign In

Popular Status

See all
YoilishRockland DailyAvrumie TreuhaftChaim GreenMeilech BraunsteinMKY MomentsCrown Heights ShomrimSee all 63

Trending

See all
Matzav
6 hours ago

KASHRUS ALERT: Surprise Inspection at Israeli Doughnut Factory Uncovers Unexpected Bishul Akum Concern Ahead of Chanukah

Matzav6 hours ago

KASHRUS ALERT: Surprise Inspection at Israeli Doughnut Factory Uncovers Unexpected Bishul Akum Concern Ahead of Chanukah

A surprise kashrus inspection at a large sufganiyah factory in Ashdod uncovered an unexpected halachic concern after rabbonim discovered that a non-Jewish employee was manually turning doughnuts that failed to flip automatically during frying, raising questions about bishul akum and prompting an immediate change in the factory’s production procedures.

The incident, recounted by kashrus expert Rav Yochanan Reichman, occurred as the factory was preparing for the busy Chanukah season, producing thousands of sufganiyos daily for stores, shuls and families throughout the area.

The production operation was largely automated. Machines prepared the dough, formed the sufganiyos and deposited them into hot oil, where an automated mechanism turned them to ensure that both sides were properly fried.

During an inspection of the facility, however, one of the visiting rabbonim noticed something that had apparently escaped attention.

Although the machinery successfully turned nearly every sufganiyah, an occasional doughnut failed to flip and remained frying on one side. When that happened, a non-Jewish worker stationed nearby would intervene and turn it over by hand.

The discovery prompted one of the rabbonim to request an immediate halt to the production line while the kashrus inspectors examined whether the employee’s involvement could render the affected sufganiyos prohibited because of bishul akum.

The concern centered on whether manually turning a sufganiyah constituted a significant act of cooking, particularly if the doughnut would not otherwise have been properly fried on both sides.

The question was complicated by a longstanding halachic disagreement concerning the status of dough that is fried rather than baked.

Rabbeinu Tam maintains that a thick dough of the kind ordinarily used for bread retains the halachic status of bread even when prepared through cooking or frying. Rabbeinu Shimshon, however, distinguishes between baked bread and dough prepared through other cooking methods.

The Shulchan Aruch, in Orach Chaim 168, generally follows the position that such fried dough does not have the status of ordinary bread.

That distinction became particularly relevant to the factory inspection because foods classified as cooked rather than baked may be subject to the laws of bishul akum.

The rabbonim also considered differences between Ashkenazic and Sephardic rulings concerning the participation required of a Jew in the cooking process.

Under the Rema’s ruling, a Jew’s involvement in lighting the fire can be sufficient in circumstances where bishul akum would otherwise apply. The Shulchan Aruch generally requires more direct Jewish participation in the cooking itself.

Consequently, even if the factory’s frying equipment had been activated by a Jew, that would not necessarily resolve every concern for a mehadrin certification intended to accommodate both communities.

Another question involved whether the non-Jewish worker’s action actually completed the frying process or merely accelerated something that would have occurred without his intervention.

One position raised during the discussion was that the sufganiyah might eventually have become fully cooked even without being turned manually. If so, the employee’s action might not constitute the kind of essential cooking intervention that creates a bishul akum prohibition.

The inspectors also examined what would happen if an affected sufganiyah became mixed with the thousands of other doughnuts produced by the factory.

That raised additional halachic questions involving bitul, including whether a sufganiyah could be considered a chatichah hare’uyah lehiskabed, an important food item that does not become nullified in an ordinary mixture, or a davar shebeminyan, an item customarily sold by individual count.

The rabbonim discussed whether those classifications applied in this particular situation and whether the fact that the sufganiyah became fully cooked only after rejoining the production stream would affect its status.

Further questions concerned the applicable rules of nullification and the extent to which the frying oil might be relevant to calculating the mixture.

The discussion also addressed the possibility of combining several halachic considerations to permit the affected products, rather than treating every doughnut touched by the employee as automatically prohibited.

Despite the various arguments that might support a lenient ruling, the kashrus authorities determined that the most appropriate solution was to eliminate the concern at its source.

The factory was instructed to remove the non-Jewish employee from the position responsible for manually turning sufganiyos and assign that responsibility exclusively to a Jewish worker.

The change allowed production to continue without relying on the disputed halachic considerations and ensured that the sufganiyos could be marketed under the factory’s mehadrin kashrus supervision.

The incident demonstrated how even a highly automated food-production process can present unexpected halachic questions when a seemingly minor manual intervention becomes part of the manufacturing procedure.

{Matzav.com}

Popular in groups

See all
Belaaz News7 hours ago
🇺🇸 - WOW: Earlier this week, a Tesla with Self-Driving engaged slows down and moves to the right. Seconds later, a speeding car passes it and crashes at an intersection. - The f…Read more
OSINT6136 hours ago
Germany's Merkel on Israel: If you try to put yourself in the position of an Israeli prime minister, it is an incredibly difficult task. If there is a bunker beneath every kinder…Read more

Popular groups

See all
MKY MomentsShared an attachmentSimcha SpotWedding of Mendel and Shaina Levitansky

Sites to follow

See all
Israel National NewsIsraeli news site with a religious-Zionist perspective covering Israel and the Jewish world.Follow
Yeshiva World NewsOrthodox Jewish news website covering breaking news, Israel updates, and community events.Follow
Cleveland Jewish NewsFollow
Jewish Breaking NewsFollow

Browse

  • Sites
  • Groups
  • Status
  • Podcasts

Jooish

  • About
  • Download the app
  • Contact
  • Support

Publish

  • Publish on Jooish
  • Add a Site
  • Add a Group
  • Add a Status feed
  • Add a Podcast

Legal

  • Privacy
  • Terms
  • Report abuse

© 2026 Jooish

Kremel
RK
VINnews
Efraim Feder
Perlowitz Show
Matzav
25 hours ago

VISA MIRACLE: Singer Gad Elbaz Credits Visit to the Yenuka With Unexpected Approval to Return to America

Matzav5 hours ago

VISA MIRACLE: Singer Gad Elbaz Credits Visit to the Yenuka With Unexpected Approval to Return to America

Jewish singer Gad Elbaz has shared an account of what he describes as a remarkable yeshuah that enabled him to return to the United States, despite warnings from his immigration attorneys that he would be unable to reenter the country.

In a message released this week, Elbaz recounted the difficulties he encountered while attempting to return to America, where his family resides and where he has established much of his personal and professional life.

According to Elbaz, he had traveled in and out of the United States for nine years using an artist visa, which was renewed every three years. However, when he recently sought to return, his attorneys informed him that his circumstances had changed and warned that he would not be permitted to enter.

The lawyers reportedly advised him to remain in Israel for an entire year before submitting another application.

Faced with the prospect of being separated from his family for an extended period, Elbaz turned to Rav Shlomo Yehuda Be’eri, widely known as the Yenuka, seeking guidance and a bracha.

“My entire family is there. My entire life is there,” Elbaz recalled telling the rov.

Elbaz said he expected Rav Be’eri to reassure him about his immigration difficulties. Instead, the rov surprised him by asking how his father was doing and then inquiring about his mother.

Despite the discouraging legal advice, Elbaz decided to proceed with his application, placing his trust in the guidance he had received.

“I’m following the advice of my rov,” he recalled telling himself.

He subsequently attended an immigration interview, uncertain whether he would be allowed to return to the United States.

To his astonishment, the interview concluded with an unexpected announcement.

“Okay, we have good news. You can enter,” Elbaz recalled being told.

Elbaz described the development as an extraordinary yeshuah, expressing his excitement and gratitude over the outcome.

“History beyond nature!” he exclaimed in the video.

Elbaz did not provide further details about the specific immigration issue or the legal basis for the approval.

{Matzav.com}

2
Belaaz
4 hours ago

WATCH: Tesla Moves Right Moments Before Speeding Car Crashes at Intersection

Belaaz4 hours ago

WATCH: Tesla Moves Right Moments Before Speeding Car Crashes at Intersection

Dashcam footage shows a Tesla slowing down and moving to the right moments before a speeding car passes it and crashes at an intersection.

The Tesla’s on-screen display shows “Self-Driving” engaged during the approach. The clips capture the scene from several angles, including damaged vehicles and debris at the intersection.

Although the footage has drawn claims that the Tesla deliberately moved to avoid the speeding car, the video does not establish why it changed position or whether the movement was an evasive response by the driving system.

The exact date of the crash and reports that the speeding driver died have not been independently confirmed by Belaaz.

Yeshiva World News
7 hours ago

BILLIONAIRE ENTERS THE FIGHT: Bloomberg Bankrolls New Charter School Group To Take On Mamdani’s Agenda

Yeshiva World News7 hours ago

BILLIONAIRE ENTERS THE FIGHT: Bloomberg Bankrolls New Charter School Group To Take On Mamdani’s Agenda

Former New York City Mayor Michael Bloomberg has seeded a brand-new charter school advocacy group with at least $1 million, opening a fresh front against Mayor Zohran Mamdani, a staunch ally of the teachers’ union and opponent of charter school growth, The New York Times reported.

The group, Great Public Schools New York, was formed this week and will be led by Kevin Elkins, a former political director of the New York City carpenters union who advised Andrew Cuomo during his failed mayoral run last year. It also has an affiliated 501(c)(4) nonprofit that can engage in political activity.

Elkins said the group will immediately push to lift the state’s cap on charter schools and to win funding parity with traditional public schools, and that it will not “be shy about building a war chest and using it.” He said the group plans to “constructively engage” with Mamdani, arguing that the mayor’s focus on affordability fits with a push for more choice in education.

“The mayor has changed his positions on several matters since he’s come into City Hall, not because he’s giving up on his ideological convictions, but because he understands that governing is a complicated task,” Elkins said. A Mamdani spokeswoman declined to comment on the new group.

Bloomberg already funds several well-financed organizations that back charter school expansion in the city, including StudentsFirstNY, which in 2023 successfully lobbied Albany to allow 14 new charter schools in the city using dormant or abandoned licenses. A person familiar with his thinking said that support is not expected to change. Other major charter backers, including Daniel Loeb and Paul Singer, have also clashed with Mamdani over his push to raise taxes on wealthy New Yorkers and his harsh criticism of Israel.

New York’s first charter school law, passed in 1998, allowed 100 charters; the Legislature raised the cap to its current 460 in 2010. About 190,000 students now attend roughly 355 charter schools statewide, most of them in New York City, with growth concentrated in the Bronx and Brooklyn. The city’s traditional school system, meanwhile, is losing students and weighing the closure or merger of hundreds of under-enrolled schools.

(YWN World Headquarters – NYC)

Vos Iz Neias
151 day ago

Orthodox Jewish Couple Behind $100 Million Furniture Business Say Trump’s Tariff Policies Left Them Disappointed

Vos Iz Neias1 day ago

Orthodox Jewish Couple Behind $100 Million Furniture Business Say Trump’s Tariff Policies Left Them Disappointed

MIAMI BEACH — An Orthodox Jewish couple who built a furniture business generating more than $100 million in annual revenue say they are disappointed with President Donald Trump’s trade policies after an ambitious attempt to bring manufacturing jobs back to the United States cost them $3 million and ultimately failed.

Bruce and Chaya Krinsky, co-founders of TOV Furniture, supported Trump, with Bruce voting for him three times because he believed the president was the most pro-business candidate. But after navigating years of shifting tariffs and trade policies, Krinsky says the administration has fallen short of his expectations.

“I came in really hoping that this administration would be really positive for business,” Krinsky told The Wall Street Journal in an interview published Tuesday. He added that he wished the administration were more in touch with the realities facing businesses.

The couple built TOV Furniture into a major player in the affordable contemporary furniture market, targeting consumers looking for something more upscale than IKEA without paying the premium prices charged by retailers such as Crate & Barrel.

One of the company’s signature products was a sofa priced around $900. The business eventually grew to generate more than $100 million annually.

But Trump’s changing tariff policies forced the company to repeatedly reconsider where its furniture should be manufactured.

Tariffs prompted move away from China

TOV initially relied heavily on Chinese manufacturers. During Trump’s first administration, tariffs on Chinese imports pushed the company to diversify its supply chain and move some production to Vietnam.

Concerned about another round of tariffs under Trump’s second administration, Krinsky urged his primary Chinese supplier in 2023 to establish a manufacturing facility in Vietnam.

The factory opened in March 2025, employing approximately 130 workers.

However, Trump’s announcement of a proposed 46% tariff on Vietnamese imports threatened to undermine the investment. Krinsky feared that a sofa retailing for approximately $1,250 could eventually cost consumers close to $2,000.

“At $2,000, there’s no reason for us to exist,” he told the Journal.

Tried bringing jobs back to America

Rather than abandon his business model, Krinsky decided to try something the Trump administration had repeatedly encouraged American companies to do: bring manufacturing back home.

He acquired a struggling furniture factory in High Point, North Carolina, and renamed it Revival American Contract Furniture.

The factory had approximately $2.4 million in outstanding orders but was struggling financially. Krinsky took over the operation, hoping to restore American manufacturing jobs while protecting his company from overseas tariffs.

The effort quickly ran into serious problems.

The factory struggled to find skilled workers, and domestic production costs were significantly higher than those in Asia. Workers in North Carolina produced approximately two to three sofas per day, compared with roughly 10 at the company’s Asian manufacturing partners.

The cost difference proved overwhelming. A sofa that cost approximately $280 in labor and materials in Vietnam cost about $1,000 to manufacture in North Carolina, before shipping.

Krinsky said he was losing more than $100 on every sofa produced at the American facility.

After 10 months, the factory closed on July 31, leaving approximately 45 workers without jobs and costing the company about $3 million.

“It was the worst period of my life,” Krinsky said. “It was like being constantly punched in the gut.”

More tariff trouble

The company has since returned to relying primarily on its Asian manufacturing network, with approximately 70% of its furniture now produced in Vietnam.

But another dispute has emerged with U.S. Customs and Border Protection, which flagged 17 shipments totaling approximately 45 containers from the Vietnamese factory.

Authorities determined that the furniture should be classified as Chinese-made and subjected to higher tariffs. The resulting bill totaled approximately $135,000.

Krinsky disputes the determination, arguing that the products are genuinely manufactured in Vietnam, despite some machinery and materials originating in China. He submitted more than 1,000 pages of documentation, photographs and videos to support his position and hired an attorney to challenge the assessment.

White House defends Trump

Despite Krinsky’s disappointment, the White House defended the president’s trade strategy, arguing that tariffs are intended to level the playing field for American workers, expand domestic job opportunities and increase wages.

The Supreme Court subsequently struck down Trump’s global tariffs, prompting the administration to pursue additional trade measures through executive orders.

For the Krinskys, the experience has become an expensive lesson in the difficulty of operating a business amid constantly changing trade policies.

Their story also highlights the dilemma facing American manufacturers: companies are being encouraged to bring jobs back home, but domestic labor and production costs can make it difficult to compete while maintaining affordable prices.

Krinsky’s question to the administration was direct:

“What exactly is an American business supposed to do?”

15
Matzav
6 hours ago

WEIGHT-LOSS WARNING: Doctors Identify Six Health Risks That Can Follow Stopping Ozempic, Wegovy and Zepbound

Matzav6 hours ago

WEIGHT-LOSS WARNING: Doctors Identify Six Health Risks That Can Follow Stopping Ozempic, Wegovy and Zepbound

Patients who discontinue popular weight-loss medications such as Ozempic, Wegovy and Zepbound may face a series of unexpected health consequences, including the rapid return of lost weight, increased hunger, muscle loss and the reversal of improvements in blood sugar and cardiovascular health, according to a physician warning that the benefits of these drugs can be difficult to maintain after treatment ends.

Dr. Frank Dumont, an internal medicine specialist and executive medical director at San Francisco-based Virta Health, said patients should understand the potential consequences of discontinuing GLP-1 medications before deciding to stop treatment. Although the drugs have transformed the treatment of obesity and type 2 diabetes, studies indicate that many users discontinue them within their first year.

Patients abandon the medications for several reasons, including unpleasant side effects, medical complications and reluctance to remain on prescription drugs indefinitely. Nausea, vomiting, diarrhea and constipation are among the commonly reported problems, and some patients find that the medications suppress their appetite so substantially that maintaining adequate nutrition becomes difficult.

“Those types of things can become troublesome enough that people actually have a hard time eating enough food to get good nourishment,” he told Fox News Digital. “Working with your physician to make a decision about whether it’s right for you to stay on the medicine or not is important.”

More serious complications can require discontinuing treatment altogether. One such concern is acute pancreatitis, an uncommon but potentially dangerous inflammation of the pancreas that requires prompt medical attention.

“We know that’s fairly rare, but if the pancreas becomes involved, that is not a good thing,” Dumont said. “It can be very serious. It can even be life-threatening.”

Certain medications in this category also carry warnings concerning thyroid C-cell tumors, based on findings in animal research. Whether these drugs cause such tumors in humans has not been established. They are contraindicated for individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, known as MEN 2.

Dumont identified six areas of concern for patients who stop using GLP-1 medications, beginning with changes in appetite and extending to the possible loss of important long-term health benefits.

One of the earliest changes is often the return of persistent hunger and cravings. Patients who experienced relief from constant thoughts about eating while taking the medication may find those urges returning after treatment ends, a phenomenon commonly described as “food noise.”

Some individuals begin treatment believing they can use the medication temporarily, reach a desired weight or blood sugar level, and then discontinue it without difficulty. However, medical organizations, including the American Medical Association and the Obesity Medicine Association, recognize obesity as a chronic disease that frequently requires continuing treatment and management.

“Unless you have significantly changed what you’re doing in terms of the types of foods you’re eating, it’s likely you’ll go back to the same foods you were eating before, and hunger and cravings will go up,” Dumont said.

A second major concern is weight regain, which clinical research has shown can occur relatively quickly after patients discontinue treatment.

In an extension of the STEP 1 clinical trial, participants who stopped semaglutide and the accompanying lifestyle intervention regained approximately two-thirds of their previous weight loss over the following year.

Similar findings emerged from the SURMOUNT-4 trial involving tirzepatide, the active ingredient in Zepbound. Participants who were switched from the medication to a placebo after 36 weeks regained more than half of their earlier weight loss during the subsequent year, despite continuing to receive dietary and exercise guidance.

“That’s just so devastating for people who felt like they’d finally found a solution that would work,” Dumont said.

The third potential consequence involves deterioration in metabolic health indicators. While taking GLP-1 medications, many patients experience improvements in blood sugar, blood pressure and cholesterol levels. These gains can be particularly valuable for people with diabetes or prediabetes, but they may diminish after treatment is discontinued.

Dumont also warned that improvements in fatty liver disease could be reversed if patients return to eating patterns that contributed to their original metabolic problems.

“We know that these medications can help to decrease some of that steatotic or fatty liver disease that occurs,” he noted. “And when you go off the medicine, if you go back to eating the way you did before, those numbers have a tendency to worsen.”

A fourth concern is the effect of repeated weight loss and regain on body composition, particularly the possibility that patients may lose muscle during treatment and regain proportionately more fat after stopping.

“When people take the GLP-1 medications, they lose weight, but they tend to lose both fat mass and lean muscle mass,” he told Fox News Digital.

Research examining body composition during tirzepatide treatment found that approximately three-quarters of the weight lost consisted of fat, while about one-quarter was lean tissue, a category that includes muscle as well as other nonfat components.

Dumont expressed concern that patients who regain weight may not necessarily recover all the lean tissue they lost, potentially leaving them with a less favorable balance of muscle and fat after repeated treatment cycles.

“So, there’s a bit of a ratcheting-down effect if someone is on and off these medications, where they lose fat and muscle, stop the medicine, regain fat, go back on the medicine, and lose fat and muscle,” he added.

Maintaining muscle mass is particularly important for physical strength, metabolic function, mobility and reducing the likelihood of injuries, especially as patients grow older.

The fifth issue involves emotional and psychological consequences. For individuals who have struggled with their weight for years, losing progress after finally finding an effective treatment can be deeply discouraging.

Dumont said patients who have repeatedly attempted diets and weight-loss programs may regard GLP-1 medications as their best opportunity for lasting success. When treatment must be stopped or the weight returns, the experience can be especially difficult.

He described the reversal of progress as a “regression on all fronts” that can be “really devastating from a mental health standpoint.”

“It can make you feel disheartened and like you don’t have the control you thought you did,” he added.

The sixth concern is the potential loss of protection against serious medical conditions, particularly cardiovascular disease.

An observational study published in BMJ Medicine found that adults with type 2 diabetes who discontinued GLP-1 treatment experienced a higher rate of major cardiovascular events than patients who remained on the medications. Longer interruptions were associated with greater risk, although observational findings do not establish that stopping the drugs directly caused those events.

Dumont explained that the medications can improve several factors associated with heart attacks and strokes, including blood sugar regulation, cholesterol levels and inflammation. When those improvements disappear, patients may again face elevated health risks.

“But again, if you stop the medicine and you haven’t changed the way that you eat, then all of those numbers can worsen … and that can then increase the risk of those bad things happening — things that can be devastating from a life quality standpoint, but also can shorten your life,” he warned.

Despite these concerns, Dumont emphasized that discontinuing GLP-1 medications does not inevitably mean losing all the benefits achieved during treatment. He said patients who make substantial, sustainable dietary changes and reach important metabolic goals may be better positioned to maintain their progress.

“We actually have peer-reviewed published data demonstrating that you can indeed stop one of these medications when you reach your metabolic goals,” he said.

The research he referenced involved selected patients with type 2 diabetes participating in a structured nutritional treatment program associated with Virta Health. Because the study examined a particular patient population and treatment approach, its findings may not apply to everyone taking GLP-1 medications.

“The GLP-1 is not the only solution,” he said. “It needs to be coupled with … a way of eating that’s going to work for you for the long term that allows you to stop the medicine successfully if you need to.”

Dumont advised patients considering discontinuation to consult their prescribing physician, develop a realistic long-term nutrition plan and continue monitoring their weight and blood sugar levels after treatment ends.

A closer look at the clinical evidence reinforces the concern about weight returning after treatment ends. In the STEP 1 extension, participants taking semaglutide initially lost an average of 17.3% of their body weight. One year after discontinuation, their average weight remained 5.6% below where they started, demonstrating that some benefits persisted even though much of the earlier weight loss had been reversed.

The SURMOUNT-4 trial, published in the Journal of the American Medical Association, similarly found that patients who continued tirzepatide maintained or increased their weight loss, while those switched to placebo experienced substantial regain. Researchers concluded that continuing treatment was considerably more effective for maintaining weight reduction than withdrawing the medication.

These findings have prompted growing discussion among obesity specialists about whether GLP-1 medications should be viewed primarily as long-term treatments rather than temporary weight-loss interventions. For patients who need to discontinue them because of side effects, cost or other medical considerations, physicians emphasize the importance of individualized follow-up rather than assuming the results will automatically last.

{Matzav.com}

MDY MomentsBanias > Jordan River > Mediterranean Sea ?
AI Tips and TricksIn response to people kvetching about various features they can't find in an app to manage yahrzeits, this is my gift to the oilam... https://yyenta.vitursa.com/ credit to feedback contributors + Claude Opus 5.5.
TLS - The Lakewood ScoopPSA: The QuickChek gas station in Lakewood is currently out of gas
Kol HaolamSHIP COLLISION: A cargo ship slammed into a river cruise reportedly carrying more than 100 people near the Port of New Orleans in Louisiana, major rescue ongoing.
Yeshiva World NewsUS Air Force personnel at RAF Lakenheath, a major American air base in Suffolk, England, responded on Friday to "suspected unauthorized drone activity" over the base, a US Air Force spokesperson confirmed. No personnel, aircraft or infrastructure were affected. The incident comes days after nine US refueling tankers were relocated from nearby RAF Mildenhall to bases in the UK, Germany and Spain amid heightened concerns over Iranian threats to American bases in Britain.
JewasityZoox's robotaxis are now driving around Northwest Atlanta. For now, rides are limited to employees, their family and friends. A waitlist is coming soon, and the company plans to expand its service area later this year.
See all 53
Vos Iz NeiasOrthodox Jewish breaking news site covering US, Israel, and community news.
Follow
Boropark24Local news site serving the Orthodox Jewish community of Boro Park, Brooklyn.Follow
JBizNewsFollow
MatzavOrthodox Jewish news platform covering breaking news and Torah content.Follow
See all 29